From April 1, 2022 to June 30, 2022, the company has repurchased 175,000 shares, representing 0.07% for CNY 28.94 million. With this, the company has completed the repurchase of 500,000 shares, representing 0.2% for CNY 113.76 million under the buyback announced on January 23, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
21.5 HKD | +0.70% | +5.13% | -8.70% |
Apr. 29 | CanSino Biologics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 22 | Cansino Bio Gets Nod for China Clinical Trials of Haemophilus Influenzae Vaccine | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-8.70% | 1.18B | |
-2.32% | 92.59B | |
+3.68% | 41.43B | |
-10.90% | 33.49B | |
-19.56% | 14.62B | |
-9.06% | 12.77B | |
-11.34% | 11.58B | |
-43.53% | 11.35B | |
+3.75% | 8.97B | |
-6.32% | 8.3B |
- Stock Market
- Equities
- 6185 Stock
- News CanSino Biologics Inc.
- Tranche Update on CanSino Biologics Inc.'s Equity Buyback Plan announced on January 23, 2022.